Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma

Abstract Glioblastoma (GBM), an aggressive brain tumour associated with poor prognosis and high recurrence rate, has limited clinical treatment options. However, novel immunotherapeutics targeting over-presented epitopes of tumour-associated antigens (TAAs) represent a promising solution. Here we de...

Full description

Bibliographic Details
Published in:	Cancer Immunology, Immunotherapy
Main Authors:	Johannes Lutz, Randi K. Feist, Tim Sonntag, Esteban Peguero-Sánchez, Katharina Wolter, Ronja Bick, Jens Bauer, Juliane S. Walz, Regina Heidenreich
Format:	Article
Language:	English
Published:	Springer 2025-10-01
Subjects:	Glioblastoma Immunotherapy mRNA-based immunotherapeutic Cancer vaccine
Online Access:	https://doi.org/10.1007/s00262-025-04178-x

Similar Items

Viral Control of Glioblastoma
by: Nicole Mihelson, et al.
Published: (2021-06-01)

Comprehensive analysis reveals CLDN9 is a new biomarker in human cancers and immunotherapeutic target for glioblastoma multiforme
by: Yuanyuan Zhu, et al.
Published: (2025-06-01)

Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine
by: Sama Barati, et al.
Published: (2025-09-01)

Promising immunotherapeutic approaches for primary effusion lymphoma
by: Jutatip Panaampon, et al.
Published: (2024-06-01)

Immunotherapeutic Agents for Intratumoral Immunotherapy
by: Chih-Rong Shyr, et al.
Published: (2023-11-01)

Editorial: Molecular mechanisms and immunotherapeutic targets in nanomedicine-based cancer therapy
by: Rabeea Siddique, et al.
Published: (2024-09-01)

Evaluation of immunotherapeutic effects of aloe vera polysaccharides against coccidiosis in chicken
by: Kashfa KHALIQ, et al.
Published: (2017-07-01)

Emerging Nano‐Immunotherapeutic Approaches to Glioma
by: Jin Nan, et al.
Published: (2023-08-01)

Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
by: Xiangjun Tang, et al.
Published: (2019-11-01)

A second-generation, self-amplifying COVID-19 Vaccine: World’s first approval and distribution in the Japanese market with vaccine hesitancy
by: Toshio Naito
Published: (2025-12-01)

Novel immunotherapeutics against LGR5 to target multiple cancer types
by: Hung-Chang Chen, et al.
Published: (2024-08-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
by: Asim Farooq, et al.
Published: (2022-09-01)

Immunotherapeutic Approaches for Glioblastoma Treatment
by: Nasser K. Yaghi, et al.
Published: (2022-02-01)

POTENTIAL ANALYSIS OF HERBAL ACTIVE COMPOUNDS AS IMMUNOTHERAPEUTIC AGENTS AGAINST CLTA-4 RECEPTOR THROUGH IN-SILICO
by: Darlene Nabila Zetta, et al.
Published: (2025-04-01)

mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses
by: Parisa Azimi, et al.
Published: (2024-05-01)

Immunotherapeutic advancements for glioblastoma
by: Leonel eAmpie, et al.
Published: (2015-01-01)

Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance
by: Shuai Wang, et al.
Published: (2025-05-01)

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
by: Erin Kuang, et al.
Published: (2022-06-01)

Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia
by: Sunil Kumar, et al.
Published: (2021-06-01)

Immunotherapeutic Treatment for Metastatic Prostate Cancer: A Review of Recent Clinical Trials
by: Toheeb Adedolapo Jumah, et al.
Published: (2024-12-01)

Immunotherapeutics and other anticancer agents in the management of advanced gastric cancer
by: Kajetan Kiełbowski, et al.
Published: (2022-10-01)

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
by: Changwu Wu, et al.
Published: (2022-07-01)

Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures
by: Xinke Zhang, et al.
Published: (2021-08-01)

Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches
by: Haoyang Chen, et al.
Published: (2024-09-01)

A CD8+ T cell-associated immune gene panel for prediction of the prognosis and immunotherapeutic effect of melanoma
by: Shanwen Sun, et al.
Published: (2022-10-01)

Editorial: Application of artificial intelligence in improving immunotherapeutic efficacy
by: Jie Li, et al.
Published: (2022-12-01)

Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules
by: Isabelle Legastelois, et al.
Published: (2017-04-01)

COVID-19: benefits and risks of passive immunotherapeutics
by: Ankur Gupta, et al.
Published: (2020-12-01)

Design of a novel multiepitope vaccine against glioblastoma by in silico approaches
by: Sako Mirzaie, et al.
Published: (2025-07-01)

Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
by: Iman Karimi-Sani, et al.
Published: (2024-10-01)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
by: Kang Yu, et al.
Published: (2023-04-01)

Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis
by: Pengxuan Zhao, et al.
Published: (2022-12-01)

Editorial: Impact of the inflammatory microenvironment on immune infiltration in colorectal and liver cancers: insights for new immunotherapeutic strategies
by: Yuchuan Jiang, et al.
Published: (2025-10-01)

Screening and identifying a novel M-MDSCs-related gene signature for predicting prognostic risk and immunotherapeutic responses in patients with lung adenocarcinoma
by: Geng-Chong Wang, et al.
Published: (2023-01-01)

Pygo2+ T cells possess immunosuppressive features and inferior immunotherapeutic response in gastric cancer
by: Weilong Chang, et al.
Published: (2025-07-01)

Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
by: Yanlin Wu, et al.
Published: (2023-06-01)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
by: Liu F, et al.
Published: (2021-02-01)

ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts
by: Fangli Jiang, et al.
Published: (2023-08-01)

Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics—yesterday, today, and tomorrow
by: Elhoucine Elfatimi, et al.
Published: (2025-07-01)

Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer
by: Jianqiang Nie, et al.
Published: (2023-06-01)